



a* Kathrin A. Wichmann,
a,b Thomas Doert
c
and Garth J. S. Cooper
b,d,e
aSchool of Chemical Sciences, The University of Auckland, Private Bag 92019,
Auckland, New Zealand,
bSchool of Biological Sciences, The University of
Auckland, Private Bag 92019, Auckland, New Zealand,
cDepartment of Chemistry
and Food Chemistry, Technical University of Dresden, 01062 Dresden, Germany,
dCentre for Advanced Discovery and Experimental Therapeutics, NIHR Manchester
Biomedical Research Centre, Central Manchester University, Hospitals NHS,
Foundation Trust, York Place, Manchester M13 9WL, England, and
eSchool of
Medicine, University of Manchester, Oxford Road, Manchester M13, England
Correspondence e-mail: t.soehnel@auckland.ac.nz
Received 19 December 2011; accepted 23 December 2011
Key indicators: single-crystal X-ray study; T = 150 K; mean  (C–C) = 0.002 A ˚;
R factor = 0.039; wR factor = 0.087; data-to-parameter ratio = 17.6.
The crystal structure of the title diprotonated diacetyltriethyl-
enetetramine (DAT) perchorate salt, C10H24N4O2
2+ 2ClO4
 ,
can be described as a three-dimensional assembly of
alternating layers consisting of diprotonated diacetyltriethyl-
enetetramine (H2DAT)
2+ strands along [100] and the anionic
species ClO4
 . The (H2DAT)
2+ cations in the strands are
connected via N—H   O hydrogen bonding between the
acetyl groups and the amine groups of neighbouring
(H2DAT)
2+ cations. Layers of (H2DAT)
2+ strands and
perchlorate anions are connected by a network of hydrogen
bonds between the NH and NH2 groups and the O atoms of
the perchlorate anion. The asymmetric unit consits of one
perchlorate anion in a general position, as well as of one cation
that is located on a center of inversion.
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For background to pharmaceutical chelating agents in the
treatment of diabetes, see: Cooper et al. (2004); Gong et al.
(2006, 2008); Ju ¨llig et al. (2007); Lu et al. (2010). For the
detection of a new group of TETA metabolites, see: Lu et al.
(2007). For the preparation and characterization of DAT
mono- and dihydrochloride salts, see: Jonas et al. (2006);
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a = 6.0888 (5) A ˚
b = 10.9415 (9) A ˚
c = 14.8160 (11) A ˚
  = 110.846 (6) 
V = 922.44 (13) A ˚ 3
Z =2
Mo K  radiation
  = 0.41 mm
 1
T = 150 K
0.45   0.35   0.17 mm
Data collection
Stoe IPDS II diffractometer
Absorption correction: numerical
(X-RED32; Stoe & Cie, 2001)
Tmin = 0.837, Tmax = 0.936
11528 measured reﬂections
2113 independent reﬂections












 max = 0.38 e A ˚  3
 min =  0.42 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N3—H3   O4 0.88 2.12 2.989 (2) 167
N6—H6A   O1
i 0.92 1.77 2.6745 (19) 168
N6—H6B   O2
ii 0.92 2.13 2.9265 (17) 145
N6—H6B   O5
ii 0.92 2.40 3.2141 (19) 147
Symmetry codes: (i) x   1;y;z; (ii)  x þ 1;y þ 1
2; z þ 3
2.
Data collection: X-AREA (Stoe & Cie, 2002); cell reﬁnement: X-
AREA; data reduction: X-AREA; program(s) used to solve structure:
SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne structure:
SHELXL97 (Sheldrick, 2008); molecular graphics: VESTA (Momma
& Izumi, 2011); software used to prepare material for publication:
publCIF (Westrip, 2010).
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3,12-Diaza-6,9-diazonia-2,13-dioxotetradecane bis(perchlorate)
T. Söhnel, K. A. Wichmann, T. Doert and G. J. S. Cooper
Comment
As part of a larger project focusing on TETA and its metabolites as pharmaceutical chelating agents in Diabetes treatment
(Cooper et al., 2004, Gong et al. 2006, 2008, Jüllig et al. 2007, Lu et al. 2010), we previously published the detection of a
new group of TETA metabolites, N1-Monoacetyltriethylenetetramine (MAT) and the N1, N10-Diacetyltriethylenetetramine
(DAT) (Lu et al. 2007), as well as just recently the development of a new selective synthetic route and the characterization
of the DAT mono- and dihydrochloride salts (Wichmann et al., 2011).
TETA and its metabolites belong into the polyamine family, ambivalent and multidentate ligands, which are well known
for their ability to form a variety of interesting open-chain, macrocyclic and three-dimensional architectures. TETA salts
exist in variable protonation states with different anionic species (Ilioudis, et al. 2000, 2002, 2003, Elaoud et al. 1999, Fu et
al. 2005, Wichmann et al. 2007). Therefore, we investigated the metabolite forms MAT and DAT towards their protonation
and complexation behaviour (Wichmann et al., 2011). The obtained crystal structure of the new DAT salt [(H2DAT) * 2
ClO4] is described in this paper.
The (H2DAT)2+ cations are arranged as a linear symmetric chain with the terminal NH—CO—CH3 groups in trans-po-
sition to each other (Fig. 1).
The crystal structure consists of a three-dimensional-network, containing alternating assembly of two-dimensional-layers
of (H2DAT)2+ cations (Fig. 2) and the ClO4
- anions. The (H2DAT)2+ cations form linear strands along [100] (Fig. 3),
connected via hydrogen bonding between the acetyl groups and the amine groups of neighbouring (H2DAT)2+ cations, with
a C2=O1 ··· H6A/N6 distance of 1.767 (1) Å. These linear strands of the (H2DAT)2+ cations form two-dimensional-layers
in the (001) plane. However, the two-dimensional-layers of (H2DAT)2+ cations and the perchlorate anions were stabilized
by a network of intermolecular hydrogen bonds between the NH– and NH2-groups and the oxygen atoms of the perchlorate
anion, with N6—H6B···O2—Cl1—O4···H3—N3 between 2.126 (1) Å and 2.125 (1) Å, (Table 1). The terminal NH-groups
of a (H2DAT)2+ cation binds to an O-atom of a perchlorate anion, which itself bound to an internal NH-group of another
(H2DAT)2+ cation and vice versa. Therefore each (H2DAT)2+ cation is connected to four different (H2DAT)2+ cations, two
from the above and two from the below layer.
Experimental
The DAT * 2 HCl powder material was synthesized by CarboGen, Switzerland according to literature procedure (Jonas
et al. 2006, Wichmann et al. 2011). Cu(ClO4)2 is commercially available and was used as received. Crystals of the title
compound were grown by slow evaporation of an aqueous solution of DAT * 2 HCl and Cu(ClO4)2 in stoichiometric ratio
in water over a period of 6 weeks.supplementary materials
sup-2
Refinement
H atoms bonded to C and N atoms were positioned geometrically (C—H = 0.98–0.99 Å, N—H = 0.88–0.92 Å) and refined
using a riding-model approximation, with Uiso(H) = 1.5 Ueq(C, N).
Figures
Fig. 1. Crystal structure of the title compound with labeling and displacement ellipsoids
drawn at the 75% probabiliyt level. [symmetry code: (i) -x, -y - z + 1].
Fig. 2. Crystal structure of the title compound with view along the a axis. Hydrogen bonding
interactions are shown as dashed lines.






− F(000) = 452
Mr = 431.23 Dx = 1.553 Mg m−3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybc Cell parameters from 12054 reflections
a = 6.0888 (5) Å θ = 4.7–59.0°
b = 10.9415 (9) Å µ = 0.41 mm−1
c = 14.8160 (11) Å T = 150 K
β = 110.846 (6)° Not regular, colourless






Radiation source: fine-focus sealed tube 1624 reflections with I > 2σ(I)
graphite Rint = 0.114supplementary materials
sup-3
Image plate detector scans θmax = 27.5°, θmin = 2.4°
Absorption correction: numerical
(X-RED32; Stoe & Cie, 2001) h = −7→6
Tmin = 0.837, Tmax = 0.936 k = −14→14
11528 measured reflections l = −19→19
Refinement
Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full
Hydrogen site location: inferred from neighbouring
sites
R[F2 > 2σ(F2)] = 0.039 H-atom parameters constrained
wR(F2) = 0.087
w = 1/[σ2(Fo
2) + (0.0435P)2 + 0.0412P]
where P = (Fo
2 + 2Fc
2)/3
S = 1.03 (Δ/σ)max = 0.001
2113 reflections Δρmax = 0.38 e Å−3
120 parameters Δρmin = −0.42 e Å−3
0 restraints
Extinction correction: SHELXL97 (Sheldrick, 2008),
Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct
methods Extinction coefficient: 0.0082 (19)
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
O1 0.7492 (2) −0.27758 (14) 0.49858 (8) 0.0292 (3)
N3 0.4849 (2) −0.35281 (14) 0.55667 (8) 0.0203 (3)
H3 0.4552 −0.3783 0.6075 0.030*
N6 0.1286 (2) −0.15588 (13) 0.49690 (8) 0.0180 (3)
H6A 0.0102 −0.2008 0.5058 0.027*
H6B 0.2493 −0.1497 0.5556 0.027*
C1 0.8854 (3) −0.3315 (2) 0.66635 (12) 0.0306 (4)
H1A 0.9869 −0.4013 0.6669 0.046*
H1B 0.8082 −0.3455 0.7133 0.046*
H1C 0.9805 −0.2570 0.6835 0.046*
C2 0.7025 (3) −0.31761 (17) 0.56731 (10) 0.0212 (3)supplementary materials
sup-4
C4 0.2944 (3) −0.35009 (17) 0.46258 (10) 0.0218 (4)
H4A 0.1589 −0.3965 0.4668 0.033*
H4B 0.3476 −0.3914 0.4145 0.033*
C5 0.2149 (3) −0.22157 (17) 0.42777 (10) 0.0211 (3)
H5A 0.3478 −0.1757 0.4205 0.032*
H5B 0.0875 −0.2255 0.3637 0.032*
C7 0.0392 (3) −0.03159 (17) 0.46280 (11) 0.0230 (4)
H7A −0.0947 −0.0376 0.4008 0.035*
H7B 0.1647 0.0169 0.4518 0.035*
Cl1 0.43802 (6) −0.55724 (4) 0.77065 (2) 0.02264 (14)
O2 0.4296 (2) −0.55967 (14) 0.86654 (8) 0.0337 (3)
O3 0.2285 (3) −0.60503 (17) 0.70295 (10) 0.0478 (4)
O4 0.4650 (3) −0.43253 (15) 0.74660 (10) 0.0461 (4)
O5 0.6382 (3) −0.62675 (18) 0.77258 (10) 0.0507 (5)
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0253 (6) 0.0377 (9) 0.0282 (5) −0.0049 (6) 0.0139 (5) −0.0020 (5)
N3 0.0192 (6) 0.0211 (8) 0.0200 (6) 0.0012 (6) 0.0062 (5) 0.0024 (5)
N6 0.0164 (6) 0.0183 (7) 0.0180 (5) 0.0012 (6) 0.0044 (4) 0.0009 (5)
C1 0.0222 (8) 0.0346 (12) 0.0290 (8) 0.0027 (8) 0.0020 (6) 0.0014 (8)
C2 0.0204 (7) 0.0180 (9) 0.0251 (7) 0.0018 (7) 0.0081 (6) −0.0024 (6)
C4 0.0192 (7) 0.0211 (9) 0.0226 (7) −0.0001 (7) 0.0041 (5) −0.0031 (6)
C5 0.0214 (7) 0.0231 (9) 0.0185 (6) 0.0032 (7) 0.0069 (5) 0.0001 (6)
C7 0.0251 (8) 0.0201 (9) 0.0265 (7) 0.0083 (7) 0.0124 (6) 0.0060 (6)
Cl1 0.0200 (2) 0.0276 (2) 0.01913 (18) 0.00163 (17) 0.00557 (13) 0.00246 (15)
O2 0.0382 (7) 0.0424 (9) 0.0237 (6) 0.0036 (7) 0.0150 (5) 0.0075 (5)
O3 0.0355 (8) 0.0518 (11) 0.0400 (7) −0.0072 (8) −0.0063 (6) −0.0065 (7)
O4 0.0564 (9) 0.0378 (10) 0.0441 (7) −0.0072 (8) 0.0180 (7) 0.0166 (7)
O5 0.0381 (8) 0.0661 (13) 0.0463 (8) 0.0256 (8) 0.0130 (6) −0.0092 (8)
Geometric parameters (Å, °)
O1—C2 1.231 (2) C4—C5 1.517 (2)
N3—C2 1.334 (2) C4—H4A 0.9900
N3—C4 1.4622 (17) C4—H4B 0.9900
N3—H3 0.8800 C5—H5A 0.9900
N6—C7 1.485 (2) C5—H5B 0.9900
N6—C5 1.492 (2) C7—C7i 1.515 (3)
N6—H6A 0.9200 C7—H7A 0.9900
N6—H6B 0.9200 C7—H7B 0.9900
C1—C2 1.501 (2) Cl1—O3 1.4129 (13)
C1—H1A 0.9800 Cl1—O5 1.4284 (15)
C1—H1B 0.9800 Cl1—O4 1.4344 (16)
C1—H1C 0.9800 Cl1—O2 1.4401 (12)
C2—N3—C4 121.60 (13) N3—C4—H4B 109.0
C2—N3—H3 119.2 C5—C4—H4B 109.0supplementary materials
sup-5
C4—N3—H3 119.2 H4A—C4—H4B 107.8
C7—N6—C5 112.56 (12) N6—C5—C4 111.17 (13)
C7—N6—H6A 109.1 N6—C5—H5A 109.4
C5—N6—H6A 109.1 C4—C5—H5A 109.4
C7—N6—H6B 109.1 N6—C5—H5B 109.4
C5—N6—H6B 109.1 C4—C5—H5B 109.4
H6A—N6—H6B 107.8 H5A—C5—H5B 108.0
C2—C1—H1A 109.5 N6—C7—C7i 110.03 (16)
C2—C1—H1B 109.5 N6—C7—H7A 109.7
H1A—C1—H1B 109.5 C7i—C7—H7A 109.7
C2—C1—H1C 109.5 N6—C7—H7B 109.7
H1A—C1—H1C 109.5 C7i—C7—H7B 109.7
H1B—C1—H1C 109.5 H7A—C7—H7B 108.2
O1—C2—N3 121.11 (13) O3—Cl1—O5 111.45 (11)
O1—C2—C1 122.39 (15) O3—Cl1—O4 109.27 (10)
N3—C2—C1 116.49 (14) O5—Cl1—O4 109.82 (11)
N3—C4—C5 113.08 (13) O3—Cl1—O2 110.69 (9)
N3—C4—H4A 109.0 O5—Cl1—O2 107.47 (8)
C5—C4—H4A 109.0 O4—Cl1—O2 108.06 (10)
Symmetry codes: (i) −x, −y, −z+1.
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N3—H3···O4 0.88 2.12 2.989 (2) 167.
N6—H6A···O1ii 0.92 1.77 2.6745 (19) 168.
N6—H6B···O2iii 0.92 2.13 2.9265 (17) 145.
N6—H6B···O5iii 0.92 2.40 3.2141 (19) 147.
Symmetry codes: (ii) x−1, y, z; (iii) −x+1, y+1/2, −z+3/2.supplementary materials
sup-6
Fig. 1supplementary materials
sup-7
Fig. 2supplementary materials
sup-8
Fig. 3